These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 8604553)

  • 41. An Actinobacillus pleuropneumoniae PCR typing system based on the apx and omlA genes--evaluation of isolates from lungs and tonsils of pigs.
    Gram T; Ahrens P; Andreasen M; Nielsen JP
    Vet Microbiol; 2000 Jul; 75(1):43-57. PubMed ID: 10865151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decay of acquired colostral antibodies to Actinobacillus pleuropneumoniae in pigs.
    Vigre H; Ersbøll AK; Sørensen V
    J Vet Med B Infect Dis Vet Public Health; 2003 Nov; 50(9):430-5. PubMed ID: 14633196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of protective immunity by aerosol or oral application of candidate vaccines in a dose-controlled pig aerosol infection model.
    Hensel A; van Leengoed LA; Szostak M; Windt H; Weissenböck H; Stockhofe-Zurwieden N; Katinger A; Stadler M; Ganter M; Bunka S; Pabst R; Lubitz W
    J Biotechnol; 1996 Jan; 44(1-3):171-81. PubMed ID: 8717401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness of doxycycline in the prevention of an experimental infection with Actinobacillus pleuropneumoniae in pigs.
    Luque I; Tarradas C; Carrasco L; Torroella E; Artigas C; Perea A
    J Vet Med B Infect Dis Vet Public Health; 2000 Aug; 47(6):445-51. PubMed ID: 11014066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mucosal and serum IgA antibodies in pigs following infection with Actinobacillus pleuropneumoniae.
    Loftager MK; Eriksen L; Nielsen R
    Adv Exp Med Biol; 1995; 371B():935-8. PubMed ID: 7502930
    [No Abstract]   [Full Text] [Related]  

  • 46. Cross-protection experiments in pigs vaccinated with Actinobacillus pleuropneumoniae subtypes 1A and 1B.
    Jolie RA; Mulks MH; Thacker BJ
    Vet Microbiol; 1995 Aug; 45(4):383-91. PubMed ID: 7483251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic and local antibody responses after experimental infection with Actinobacillus pleuropneumoniae in piglets with passive or active immunity.
    Krejci J; Nechvatalova K; Kudlackova H; Faldyna M; Kucerova Z; Toman M
    J Vet Med B Infect Dis Vet Public Health; 2005 May; 52(4):190-6. PubMed ID: 16000115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experimental infection of SPF pigs with Actinobacillus pleuropneumoniae serotype 9 alone or in association with Mycoplasma hyopneumoniae.
    Marois C; Gottschalk M; Morvan H; Fablet C; Madec F; Kobisch M
    Vet Microbiol; 2009 Mar; 135(3-4):283-91. PubMed ID: 18977616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The importance of secreted virulence factors in Actinobacillus pleuropneumoniae bacterin preparation: a comparison.
    Fedorka-Cray PJ; Stine DL; Greenwald JM; Gray JT; Huether MJ; Anderson GA
    Vet Microbiol; 1993 Oct; 37(1-2):85-100. PubMed ID: 8296454
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
    Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF
    Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical and laboratory diagnostic findings in chronic pleuropneumonia of swine].
    Hennig I; Waldmann KH; Ganter M; Gerlach GF
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 1998 Apr; 26(2):78-84. PubMed ID: 9587973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibodies against Actinobacillus pleuropneumoniae serotype 2 in mucosal secretions and sera of infected pigs as demonstrated by an enzyme-linked immunosorbent assay.
    Loftager MK; Eriksen L; Nielsen R
    Res Vet Sci; 1993 Jan; 54(1):57-62. PubMed ID: 8434149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transmission of Actinobacillus pleuropneumoniae in pigs under field-like conditions: emphasis on tonsillar colonisation and passively acquired colostral antibodies.
    Vigre H; Angen Ø; Barfod K; Lavritsen DT; Sørensen V
    Vet Microbiol; 2002 Oct; 89(2-3):151-9. PubMed ID: 12243892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of antibodies to Actinobacillus pleuropneumoniae serotype 12 in pig serum using a blocking enzyme-linked immunosorbent assay.
    Andresen LO; Klausen J; Barfod K; Sørensen V
    Vet Microbiol; 2002 Oct; 89(1):61-7. PubMed ID: 12223163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae.
    Xu F; Chen X; Shi A; Yang B; Wang J; Li Y; Guo X; Blackall PJ; Yang H
    Vet Microbiol; 2006 Dec; 118(3-4):230-9. PubMed ID: 16930871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.
    van den Bosch H; Frey J
    Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin 6, serum amyloid A and haptoglobin as markers of treatment efficacy in pigs experimentally infected with Actinobacillus pleuropneumoniae.
    Hultén C; Johansson E; Fossum C; Wallgren P
    Vet Microbiol; 2003 Aug; 95(1-2):75-89. PubMed ID: 12860078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improved protection of swine from pleuropneumonia by vaccination with proteinase K-treated outer membrane of Actinobacillus (Haemophilus) pleuropneumoniae.
    Chiang YW; Young TF; Rapp-Gabrielson VJ; Ross RF
    Vet Microbiol; 1991 Mar; 27(1):49-62. PubMed ID: 2048282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Host-pathogen interplay at primary infection sites in pigs challenged with Actinobacillus pleuropneumoniae.
    Sassu EL; Frömbling J; Duvigneau JC; Miller I; Müllebner A; Gutiérrez AM; Grunert T; Patzl M; Saalmüller A; von Altrock A; Menzel A; Ganter M; Spergser J; Hewicker-Trautwein M; Verspohl J; Ehling-Schulz M; Hennig-Pauka I
    BMC Vet Res; 2017 Feb; 13(1):64. PubMed ID: 28245826
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nasal immunization with M cell-targeting ligand-conjugated ApxIIA toxin fragment induces protective immunity against Actinobacillus pleuropneumoniae infection in a murine model.
    Park J; Seo KW; Kim SH; Lee HY; Kim B; Lim CW; Kim JH; Yoo HS; Jang YS
    Vet Microbiol; 2015 May; 177(1-2):142-53. PubMed ID: 25818577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.